Digitalis Ventures — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Alterome is a clinical-stage precision oncology company developing small molecule therapies targeting mutant KRAS and AKT E17K in cancers including non-small cell lung, pancreatic, colorectal, endometrial, and breast cancer.
BiotechHealthtechMedical DevicesSan Diego, US
Eric A. Murphy(Executive Officer, Director, Promoter)Ryan B. Corcoran(Director, Promoter)
BoardThilo Schroeder(Director)Carl Gordon(Director)Arjun Goyal(Director)
Portfolio company acquired by Roche.
BiotechSeattle, US
Mitchell Mutz(Director)Nicholas Walrod(Director)John Mulligan(Executive Officer, Director, Promoter)Karl Handelsman(Director)
BoardJohn McKearn(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.